1 - 25 of 67 results for author:"Shipley J." in Literature citations
Results Customize
› Repeat search in UniProtKB (24)
| HES6 enhances the motility of alveolar rhabdomyosarcoma cells. Wickramasinghe C.M., Domaschenz R., Amagase Y., Williamson D., Missiaglia E., Shipley J., Murai K., Jones P.H. Exp. Cell Res. 319:103-112(2013) · Mapped (1) |
| Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome. Shipley J.G., Vandergaast R., Deng L., Mariuzza R.A., Fredericksen B.L. Virology 432:232-238(2012) · Mapped (5) |
| PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. Missiaglia E., Williamson D., Chisholm J., Wirapati P., Pierron G., Petel F., Concordet J.P., Thway K., Oberlin O., Pritchard-Jones K. et al. J. Clin. Oncol. 30:1670-1677(2012) · Mapped (2) |
| Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy. Tonelli R., McIntyre A., Camerin C., Walters Z.S., Di Leo K., Selfe J., Purgato S., Missiaglia E., Tortori A., Renshaw J. et al. Clin. Cancer Res. 18:796-807(2012) · Mapped (7) |
| Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours. Gilbert D.C., Chandler I., Summersgill B., McIntyre A., Missiaglia E., Goddard N.C., Huddart R.A., Shipley J. Int. J. Androl. 34:e114-21(2011) · Mapped (3) |
| Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas. Thway K., Selfe J., Missiaglia E., Fisher C., Shipley J. J. Clin. Pathol. 64:587-591(2011) · Mapped (10) |
| No evidence for V600E BRAF mutation in the seminoma cell line TCam-2. Goddard N.C., McIntyre A., Gilbert D., Kitazawa S., Shipley J. Genes Chromosomes Cancer 49:963-966(2010) · Mapped (3) |
| Mechanisms of emphysema in autosomal dominant cutis laxa. Hu Q., Shifren A., Sens C., Choi J., Szabo Z., Starcher B.C., Knutsen R.H., Shipley J.M., Davis E.C., Mecham R.P. et al. Matrix Biol. 29:621-628(2010) · Mapped (14) |
| Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. Williamson D., Missiaglia E., de Reynies A., Pierron G., Thuille B., Palenzuela G., Thway K., Orbach D., Lae M., Freneaux P. et al. J. Clin. Oncol. 28:2151-2158(2010) · Mapped (6) |
| Differential regulation of MAP kinase activation by a novel splice variant of human MAP kinase phosphatase-2. Cadalbert L.C., Sloss C.M., Cunningham M.R., Al-Mutairi M., McIntire A., Shipley J., Plevin R. |
| Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Kyriakides T.R., Wulsin D., Skokos E.A., Fleckman P., Pirrone A., Shipley J.M., Senior R.M., Bornstein P. Matrix Biol. 28:65-73(2009) · Mapped (5) |
| Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9. MacLauchlan S., Skokos E.A., Meznarich N., Zhu D.H., Raoof S., Shipley J.M., Senior R.M., Bornstein P., Kyriakides T.R. J. Leukoc. Biol. 85:617-626(2009) · Mapped (5) |
| TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Knight J.F., Shepherd C.J., Rizzo S., Brewer D., Jhavar S., Dodson A.R., Cooper C.S., Eeles R., Falconer A., Kovacs G. et al. Br. J. Cancer 99:1849-1858(2008) · Mapped (4) |
| DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Canzonetta C., Mulligan C., Deutsch S., Ruf S., O'Doherty A., Lyle R., Borel C., Lin-Marq N., Delom F., Groet J. et al. Am. J. Hum. Genet. 83:388-400(2008) · Mapped (12) |
| Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. Mydel P., Shipley J.M., Adair-Kirk T.L., Kelley D.G., Broekelmann T.J., Mecham R.P., Senior R.M. J. Biol. Chem. 283:9513-9522(2008) · Mapped (7) |
| KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature. Goddard N.C., McIntyre A., Summersgill B., Gilbert D., Kitazawa S., Shipley J. Int. J. Androl. 30:337-348(2007) · Mapped (7) |
| Nuclear overexpression of the E2F3 transcription factor in human lung cancer. Cooper C.S., Nicholson A.G., Foster C., Dodson A., Edwards S., Fletcher A., Roe T., Clark J., Joshi A., Norman A. et al. Lung Cancer 54:155-162(2006) · Mapped (4) |
| Microfibril-associated protein 4 binds to surfactant protein A (SP-A) and colocalizes with SP-A in the extracellular matrix of the lung. Schlosser A., Thomsen T., Shipley J.M., Hein P.W., Brasch F., Tornoe I., Nielsen O., Skjodt K., Palaniyar N., Steinhilber W. et al. Scand. J. Immunol. 64:104-116(2006) · Mapped (1) |
| Neither SP-A nor NH2-terminal domains of SP-A can substitute for SP-D in regulation of alveolar homeostasis. Zhang L., Ikegami M., Korfhagen T.R., McCormack F.X., Yoshida M., Senior R.M., Shipley J.M., Shapiro S.D., Whitsett J.A. Am. J. Physiol. Lung Cell Mol. Physiol. 291:L181-90(2006) · Mapped (13) |
| Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation. Miyamoto A., Lau R., Hein P.W., Shipley J.M., Weinmaster G. J. Biol. Chem. 281:10089-10097(2006) · Mapped (6) |
| Early emphysema in the tight skin and pallid mice: roles of microfibril-associated glycoproteins, collagen, and mechanical forces. Ito S., Bartolak-Suki E., Shipley J.M., Parameswaran H., Majumdar A., Suki B. Am. J. Respir. Cell Mol. Biol. 34:688-694(2006) · Mapped (10) |
| Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors. McIntyre A., Summersgill B., Spendlove H.E., Huddart R., Houlston R., Shipley J. Neoplasia 7:1047-1052(2005) · Mapped (10) |
| Overexpression of Stat3C in pulmonary epithelium protects against hyperoxic lung injury. Lian X., Qin Y., Hossain S.A., Yang L., White A., Xu H., Shipley J.M., Li T., Senior R.M., Du H. et al. J. Immunol. 174:7250-7256(2005) · Mapped (12) |
| Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Edwards S., Campbell C., Flohr P., Shipley J., Giddings I., Te-Poele R., Dodson A., Foster C., Clark J., Jhavar S. et al. Br. J. Cancer 92:376-381(2005) · Mapped (1) |
| Mapping of a translocation breakpoint in a Peutz-Jeghers hamartoma to the putative PJS locus at 19q13.4 and mutation analysis of candidate genes in polyp and STK11-negative PJS cases. Hearle N., Lucassen A., Wang R., Lim W., Ross F., Wheeler R., Moore I., Shipley J., Houlston R. Genes Chromosomes Cancer 41:163-169(2004) · Mapped (6) |